UK markets closed
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.78 -0.58 (-0.70%) GOLD FUTURES
2,338.30 -3.80 (-0.16%) DOW
38,346.84 -156.85 (-0.41%) Bitcoin GBP
51,829.70 -1,764.90 (-3.29%)
Merck & Co., Inc. (6MK.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 118.80 |
| Open | 118.40 |
| Bid | 118.20 x 0 |
| Ask | 118.40 x 0 |
| Day's range | 117.80 - 119.40 |
| 52-week range | 91.00 - 124.40 |
| Volume | |
| Avg. volume | 1,027 |
| Market cap | 301.674B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 913.85 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.84 (2.39%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Zacks
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
- Insider Monkey
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
- Zacks
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports first-quarter 2024 earnings.
© 2024 Yahoo. All rights reserved.